Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

MEREO BIOPHARMA GROUP PLC

(MREO)
  Report
Delayed Nasdaq  -  10:56 2022-09-27 am EDT
0.8858 USD   +7.55%
09/26Mereo BioPharma Says Rubric Capital Management Rejected Offer to Resolve Proxy Contest
MT
09/26Mereo BioPharma Offered to Settle Proxy Contest with Rubric Capital Management by Putting Rubric Principal and Second New Director on the Board
AQ
09/23Rubric Capital Management Issues Open Letter to Mereo BioPharma Shareholders
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on MEREO BIOPHARMA GROUP PLC
08/12Cantor Fitzgerald Starts Mereo BioPharma Group at Overweight With $4 Price Target
MT
06/06Needham Adjusts Price Target on Mereo BioPharma Group to $5 From $10, Reiterates Buy Ra..
MT
2021Mereo BioPharma : BTIG Initiates Mereo BioPharma at Buy Rating With $10 ..
MT
2021Mereo BioPharma : Needham Starts Mereo BioPharma Group at Buy With $10 P..
MT
Upcoming event on MEREO BIOPHARMA GROUP PLC